Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Gastroenterology. 2022 Aug 2;163(6):1510–1521.e6. doi: 10.1053/j.gastro.2022.07.071

Table 1:

Demographics – All-Randomized Population

Characteristic Placebo (N = 24) IMGX003 (N = 26) All Patients (N = 50)

Age at Baseline (years)
 n 24 26 50
 Mean (SD) 45.0 (13.88) 42.7 (10.88) 43.8 (12.34)
 Median 43.9 43.3 43.3
 Minimum, Maximum 22.8, 66.4 22.2, 62.7 22.2, 66.4
Gender
 Male 8 (33.3%) 5 (19.2%) 13 (26.0%)
 Female 16 (66.7%) 21 (80.8%) 37 (74.0%)
Ethnicity
 Hispanic 1 (4.2%) 1 (3.8%) 2 (4.0%)
 Non-Hispanic 23 (95.8%) 25 (96.2%) 48 (96.0%)
Race
 American Indian or Alaska Native 0 (0%) 0 (0%) 0 (0%)
 Asian 0 (0%) 0 (0%) 0 (0%)
 Black or African American 0 (0%) 0 (0%) 0 (0%)
 Native Hawaiian or Other Pacific Islander 0 (0%) 0 (0%) 0 (0%)
 White 24 (100.0%) 25 (96.2%) 49 (98.0%)
 Other 0 (0%) 1 (3.8%) 1 (2.0%)